Zargis Medical Corp.
Zargis Medical Corp. develops advanced diagnostic decision support
products and services for primary care physicians, pediatricians,
cardiologists and other healthcare professionals.
Zargis was formed in 2001 when Siemens Corporate Research, a
division of Siemens AG (NYSE: SI), and Speedus Corp. co-invested to
develop and market an advanced acoustic technology designed to
detect heart abnormalities identified through analysis of heart
sounds.
Cardioscan Zargis has developed Cardioscan, a computer-assisted
medical device designed to support physicians in analyzing heart
sounds for the identification of suspected systolic and diastolic
murmurs.
Cardioscan is a non-invasive device that is easy to use, portable,
and takes just minutes to perform. The device implements
voice-guided protocol and a graphical user interface while
maintaining an efficient physician workflow. Cardioscan provides a
summary of findings in terms that are readily understood by
physicians and offers an additional range of quantitative
auscultatory information that cannot be obtained through listening
alone.
As a result, Cardioscan enhances auscultation-a procedure that has
been universally employed through a stethoscope for nearly
two-hundred years.
Website: www.zargis.com
|